Genetics Institute, Schering-Plough, Wyeth-Ayerst International Inc. deal

Wyeth-Ayerst acquired rights from Schering-Plough to develop and market recombinant interleukin 11 (IL-11) in Europe, Africa

Read the full 169 word article

How to gain access

Continue reading with a
two-week free trial.